Skip to main content
. Author manuscript; available in PMC: 2020 May 4.
Published in final edited form as: Hepatology. 2019 Oct 21;71(3):907–916. doi: 10.1002/hep.30858

Figure 1.

Figure 1.

Diabetes and risk of hepatocellular carcinoma (HCC) in patients with NASH cirrhosis

A. Mayo Clinic cohort

B. UNOS cohort

The bars in the figures represent the 95% confidence intervals for the cumulative incidence rates.